Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland

Mamas, Mamas A, Sperrin, Matt, Watson, Margaret C, Coutts, Alasdair, Wilde, Katie, Burton, Christopher, Kadam, Umesh T, Kwok, Chun Shing, Clark, Allan B, Murchie, Peter, Buchan, Iain, Hannaford, Philip C and Myint, Phyo K (2017) Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland. European Journal of Heart Failure, 19 (9). 1095–1104. ISSN 1388-9842

[img]
Preview
PDF (Eur_J_Heart_Fail_Manuscript_FINAL) - Submitted Version
Download (969kB) | Preview

Abstract

Aims: To evaluate whether the survival rates of patients with heart failure (HF) in the community are better than those with a diagnosis of the 4 most common cancers in men and women in a contemporary primary care cohort in Scotland. Methods and Results: The data were obtained from the Primary Care Clinical Informatics Unit from a database of 1.75 million people registered with 393 general practices in Scotland. Sex-specific survival modeling was undertaken using Cox proportional hazards models, adjusted for potential confounders. A total of 56,658 patients were eligible to be included in the study with 147,938 person years follow up (median follow up 2.04 years). In men, heart failure (reference group; 5yrs survival 37.7%) had worse mortality outcomes than patients with prostate cancer (HR 0.61, 95%CI 0.57-0.65; 5yrs survival 49.0%), and bladder cancer (HR 0.88, 95%CI 0.81-0.96; 5yrs survival 36.5%), but better than lung cancer (HR 3.86, 95%CI 3.65-4.07; 5yrs survival 2.8%) and colorectal cancer (HR 1.23 95%CI 1.16-1.31; 5 yrs survival 25.9%). In women, patients with HF (reference group; 5yrs survival 31.9%) had worse mortality outcomes than patients with breast cancer (HR 0.55 95%CI 0.51-0.59; 5yrs survival 61.0%), but better outcomes than lung cancer (HR 3.82, 95%CI 3.60-4.05; 5yrs survival 3.6%), ovarian cancer (HR 1.98, 95%CI 1.80-2.17; 5yrs survival 19%) and colorectal cancer (HR 1.21, 95%CI 1.13-1.29; 5yrs survival 28.4%). Conclusions: Despite advances in management, heart failure remains as ‘malignant’ as some of the common cancers in both men and women.

Item Type: Article
Uncontrolled Keywords: heart failure,cancer,mortality
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 21 Apr 2017 05:10
Last Modified: 11 Jun 2020 00:22
URI: https://ueaeprints.uea.ac.uk/id/eprint/63275
DOI: 10.1002/ejhf.822

Actions (login required)

View Item View Item